Mebendazole in Enterobiasis Radiochemical and Pilot Clinical Study in 1,278 Subjects
The DOI matches its Crossref record.
Abstract
An epidemiological study conducted on 1,278 persons revealed that enterobiasis was surprisingly widespread: 75% to 97% among boarding-school children, 78% among long-term hospital patients, and at least 31% among army recruits. A single standard dose of 100 mg of mebendazole was about 90% effective against enterobiasis in both children and adults. No side effects were reported even at several times the recommended dose (100 mg) in small children. Mebendazole is practically not absorbed and probably acts by blocking the glucose uptake by nematodes in the colon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Albendazole and mebendazole are generally safe without significant side effects when used in recommended doses just for 1–3 days [2,4,9,13].”
From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [4]
In the citing paper
“This drug, in a standard dose of 100 mg single dose [45], was reported to have been satisfactory for treatment of E. vermicularis infection in adults (88% CR) as well as children (91%) [4].”
From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [4]
Citations
Cites
Still being checked.
Cited by
Drug repurposing for cancer therapy
Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443
“155 159 MBZ has been shown to potentially suppress tumor growth in various cancer cell lines and animal models through the inhibition of microtubule polymerization, a process that, when interrupted, can lead to the death of rapidly dividing cells.”
BackgroundThe benzimidazole anthelmintic agents‐a review
McKELLAR, Q. A., & SCOTT, E. W. (1990) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.1990.tb00773.x · Cited by 371
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286
Benzimidazole treatment of cystic echinococcosis
El-On, J. (2003) · Acta Tropica · doi:10.1016/s0001-706x(02)00217-6 · Cited by 172
Chemotherapy for larval echinococcosis in animals and humans: Report of a workshop
Schantz, P. M., Bossche, H., & Eckert, J. (1982) · Zeitschrift f�r Parasitenkunde Parasitology Research · doi:10.1007/bf00929509 · Cited by 166
Metadata
- Authors
- Brugmans, J. P.
- Corresponding author
- Brugmans, Jo P.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1971-07-19
- Volume
- 217
- Issue
- 3
- Pages
- 313
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4298335265
- Cited by
- 70
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 1
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
- Life Sciences › Immunology and Microbiology › Parasitology › Helminth infection and control
- Keywords
- mebendazole, enterobiasis, anthelmintic efficacy, glucose uptake inhibition, parasitic nematodes, hospitalized patients, military recruits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mebendazole in Enterobiasis Radiochemical and Pilot Clinical Study in 1,278 Subjects. https://app.cochat.ai/papers/10.1001/jama.1971.03190030039008
- The paper
- Brugmans, J. P. (1971). Mebendazole in Enterobiasis Radiochemical and Pilot Clinical Study in 1,278 Subjects. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1971.03190030039008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.